These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3691605)

  • 1. The relationship between the QT interval and plasma amiodarone concentration in patients on long-term therapy.
    Burgess CD; Siebers RW; Purdie GL; Taylor C; Maling TJ
    Eur J Clin Pharmacol; 1987; 33(2):115-8. PubMed ID: 3691605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrelationships between serum levels of amiodarone, desethylamiodarone, reverse T3 and the QT interval during long-term amiodarone treatment.
    Baerman JM; Annesley T; DiCarlo LA; Foley MK; Nicklas JM; Crevey BJ; Morady F
    Am Heart J; 1986 Apr; 111(4):644-8. PubMed ID: 3953386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individual variability of amiodarone distribution in plasma and erythrocytes: implications for therapeutic monitoring.
    Maling TJ; Siebers RW; Burgess CD; Taylor C; Purdie G
    Ther Drug Monit; 1989; 11(2):121-6. PubMed ID: 2718218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QT prolongation and the antiarrhythmic efficacy of amiodarone.
    Torres V; Tepper D; Flowers D; Wynn J; Lam S; Keefe D; Miura DS; Somberg JC
    J Am Coll Cardiol; 1986 Jan; 7(1):142-7. PubMed ID: 3941202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentration time course and pharmacological effects of a standardized oral amiodarone dosing regimen in humans.
    Brennan FJ; Brien JF; Armstrong PW
    Can J Cardiol; 1991 Apr; 7(3):117-24. PubMed ID: 2044013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation between amiodarone and desethylamiodarone plasma concentrations and electrophysiologic effects, efficacy and toxicity.
    Greenberg ML; Lerman BB; Shipe JR; Kaiser DL; DiMarco JP
    J Am Coll Cardiol; 1987 May; 9(5):1148-55. PubMed ID: 3571754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentration response relationships of amiodarone and desethylamiodarone.
    Connolly SJ; Gupta RN; Hoffert D; Roberts RS
    Am Heart J; 1988 Jun; 115(6):1208-13. PubMed ID: 3376838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The imprecision in heart rate correction may lead to artificial observations of drug induced QT interval changes.
    Malik M
    Pacing Clin Electrophysiol; 2002 Feb; 25(2):209-16. PubMed ID: 11915990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular repolarization wave variations during the amiodarone treatment course.
    Zhao H; Gu D; Ge Q
    Medicine (Baltimore); 2018 Sep; 97(38):e12330. PubMed ID: 30235687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrations.
    Escoubet B; Coumel P; Poirier JM; Maison-Blanche P; Jaillon P; Leclercq JF; Menasche P; Cheymol G; Piwnica A; Lagier G
    Am J Cardiol; 1985 Mar; 55(6):696-702. PubMed ID: 3976511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma concentrations and amiodarone/desethylamiodarone relations in patients subjected to chronic treatment].
    Ortiz M; Gaete L; Asenjo R; Fernández F; Saavedra I
    Rev Med Chil; 1996 Jan; 124(1):77-82. PubMed ID: 8762622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of desethylamiodarone in the anticoagulant effect of concurrent amiodarone and warfarin therapy.
    Naganuma M; Shiga T; Nishikata K; Tsuchiya T; Kasanuki H; Fujii E
    J Cardiovasc Pharmacol Ther; 2001 Oct; 6(4):363-7. PubMed ID: 11907638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone and desethylamiodarone distribution in the atrium and adipose tissue of patients undergoing short- and long-term treatment with amiodarone.
    Barbieri E; Conti F; Zampieri P; Trevi GP; Zardini P; d'Aranno V; Latini R
    J Am Coll Cardiol; 1986 Jul; 8(1):210-3. PubMed ID: 3711518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
    Somani P; Simon VA; McManus K
    Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic studies of amiodarone and its active N-desethyl metabolite.
    Nattel S
    J Cardiovasc Pharmacol; 1986; 8(4):771-7. PubMed ID: 2427817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of amiodarone on the circadian rhythm and power spectral changes of heart rate and QT interval: significance for the control of sudden cardiac death.
    Antimisiaris M; Sarma JS; Schoenbaum MP; Sharma PP; Venkataraman K; Singh BN
    Am Heart J; 1994 Nov; 128(5):884-91. PubMed ID: 7942479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of amiodarone dosage, heart rate, QT interval and corneal microdeposits with serum amiodarone and desethylamiodarone concentrations.
    Pollak PT; Sharma AD; Carruthers SG
    Am J Cardiol; 1989 Nov; 64(18):1138-43. PubMed ID: 2816765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of hepatic computerized tomographic scanning during amiodarone therapy.
    Markos J; Veronese ME; Nicholson MR; McLean S; Shevland JE
    Am J Cardiol; 1985 Jul; 56(1):89-92. PubMed ID: 4014047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
    Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF
    Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of amiodarone, sematilide, and sotalol on QT dispersion.
    Cui G; Sen L; Sager P; Uppal P; Singh BN
    Am J Cardiol; 1994 Nov; 74(9):896-900. PubMed ID: 7526675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.